MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bjophthalmol-2020-318672

Медицинская библиотека · The British journal of ophthalmology · 2021

Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study.

Bulirsch Louisa Maria, Saßmannshausen Marlene, Nadal Jennifer, Liegl Raffael, Thiele Sarah, Holz Frank G

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Brolucizumab has recently been approved in Europe as a novel treatment for patients with neovascular age-related macular degeneration (nAMD). We report on early experiences with real-world outcomes of switch to brolucizumab therapy in previously anti-vascular endothelial growth factor (anti-VEGF)-treated patients.

METHODS

Patients with recalcitrant nAMD were switched to brolucizumab therapy. Functional and structural parameters 4 weeks after first brolucizumab injection were evaluated including best-corrected visual acuity (BCVA (logMAR)), foveal centre point (FCP (µm)), central subfield retinal thickness (CSRT (µm)) and macular volume (mm³).

RESULTS

Sixty-three eyes of 57 patients with nAMD (52.6% females) with a mean (±SD) age of 79.5±6.7 years were included. Mean change of BCVA was 0.03±0.14 logMAR (p=0.115). Significant reductions were recorded for FCP with a mean (±SD) change of -66.81±72.63 µm, -66.76±60.71 µm for CSRT and -0.27±0.24 mm³ for macular volume (all p<0.001). Intraocular inflammation was observed in seven eyes of seven patients, including one case of retinal vasculitis.

CONCLUSIONS

The results of the SHIFT study indicate that switch to brolucizumab may represent a treatment option in patients with nAMD poorly responsive to other anti-VEGF agents. Further long-term analyses appear prudent to assess efficacy and safety of brolucizumab in a routine clinical setting.

Для цитирования: Bulirsch Louisa Maria, Saßmannshausen Marlene, Nadal Jennifer, Liegl Raffael, Thiele Sarah, Holz Frank G. Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study.. The British journal of ophthalmology. 2021. DOI: 10.1136/bjophthalmol-2020-318672.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.